News
Regulatory affairsRegulatory Round-up - December 2025
Challenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesRegulatory Round-up - April 2024Jim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive DirectorsRegulatory Round-up - March 2024Standing out: Defining the market for your new ATMP asset£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadershipRegulatory Round-up - February 2024Braintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesAn effective team strategy for cell and gene therapy venturesEducation Secretary joins Cell and Gene Therapy Catapult to celebrate apprentices